Massimo Federico is Professor of Medical Oncology, and since 2005 has been Director of the Medical Oncology and Lymphoma Unit, at the University of Modena and Reggio Emilia, Modena, Italy. He has also been the Director of the Modena Cancer Registry (Registro Tumori di Modena) since 1987.
Prof Federico earned a degree in Medicine and Surgery from the Catholic University of Rome in 1974 then undertook post-graduate studies in Hematology at the University of Modena, which he completed in 1977. Following this, he undertook a 5-year program in Internal Medicine at the University of Pavia.
Between 1988 and 1989, Prof. Federico became a Visiting Research Associate at the Department of Electrical and Computer Engineering, Bioacustic Research Laboratory of the University of Illinois, where he worked in basic research to improve the role of bone marrow imaging. Furthermore, in 1993 and 1994, he became a Visiting Research Associate at the Arizona Cancer Center of the University of Arizona, where he dedicated his research to smarter strategies and designs for controlled clinical trials, better analysis of clinical data, expertise in biostatistics/data analysis/interpretation, and investigating the role of in vitro testing of novel agents for advanced Ovarian Cancer.
Prof Federico has a broad range of translational scientific and clinical interests, spanning cancer epidemiology, hereditary breast cancer, design and conduct of clinical trials, and clinical management of Lymphoma (Hodgkin and Non-Hodgkin Lymphoma as well as Hairy Cell Leukemia). The most important work carried out by Prof. Federico in the last two decades includes investigation into prognostic factors of HL, Follicular Lymphoma, Peripheral T-Cell Lymphoma, and Splenic Marginal Zone Lymphoma, with the aim of aiding treatment choice for affected patients.
Positions of responsibility/awards:
- President of the Angela Serra Association for Cancer Research (Associazione Angela Serra per la ricerca sul cancro) since 1994
- President of Fondazione Italiana Linfomi (FIL) from 2011–2013
- President of Gruppo Italiano per lo Studio dei Linfomi (GISL) from 2002–2010
- Author and Co-Author of over 400 published articles
- Published several monographs on cancer epidemiology in the Province of Modena between 1988 and 2011
- Conducted several phase II and III clinical trials comparing different therapeutic strategies for HL, Diffuse Large B-Cell Lymphoma, indolent Lymphoma, and FL
- Member of several international societies, including the Italian Society of Haematology, the American Society of Clinical Oncology, the European Society of Medical Oncology, and the American Society of Hematology